Association between serum cholesterol levels and Alzheimer’s disease in China: a case-control study

References

• Andersen CJ, Fernandez ML. 2013. Dietary approaches to improving atheroprotective HDL functions. Food Funct. 4:1304–1313.
   PubMed Web of Science ®Google Scholar
• Arenas F, Garcia-Ruiz C, Fernandez-Checa JC. 2017. Intracellular Cholesterol Trafficking and Impact in Neurodegeneration. Front Mol Neurosci. 10:382.
   PubMed Web of Science ®Google Scholar
• Burns M, Duff K. 2002. Cholesterol in Alzheimer's disease and tauopathy. Ann N Y Acad Sci. 977:367–375.
   PubMed Web of Science ®Google Scholar
• Chan KY, Wang W, Wu JJ, Liu L, Theodoratou E, Car J, Middleton L, Russ TC, Deary IJ, Campbell H, et al. 2013. Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990-2010: a systematic review and analysis. Lancet 381:2016–2023.
   PubMed Web of Science ®Google Scholar
• Cockerill GW, Huehns TY, Weerasinghe A, Stocker C, Lerch PG, Miller NE, Haskard DO. 2001. Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation. Circulation 103:108–112.
   PubMed Web of Science ®Google Scholar
• Cordy JM, Hooper NM, Turner AJ. 2006. The involvement of lipid rafts in Alzheimer's disease. Mol Membr Biol. 23:111–122.
   PubMed Web of Science ®Google Scholar
• Evans RM, Hui S, Perkins A, Lahiri DK, Poirier J, Farlow MR. 2004. Cholesterol and APOE genotype interact to influence Alzheimer disease progression. Neurology 62:1869–1871.
   PubMed Web of Science ®Google Scholar
• Feng F, Han XQ, Chen J, Shang L, Li J. 2004. Application of the activities of daily living rating scale in screening dementia. J Clin Psychol Med. 14:193–194.
   Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 18:499–502.
   PubMed Web of Science ®Google Scholar
• Helzner EP, Luchsinger JA, Scarmeas N, Cosentino S, Brickman AM, Glymour MM, Stern Y. 2009. Contribution of vascular risk factors to the progression in Alzheimer disease. Arch Neurol. 66:343–348.
   PubMedGoogle Scholar
• Jack CR, Jr, Albert MS, Knopman DS, McKhann GM, Sperling RA, Carrillo MC, Thies B, Phelps CH. 2011. Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7:257–262.
   PubMed Web of Science ®Google Scholar
• Kankaanpää J, Turunen SP, Moilanen V, Hörkkö S, Remes AM. 2009. Cerebrospinal fluid antibodies to oxidized LDL are increased in Alzheimer's disease. Neurobiol Dis. 33:467–472.
   PubMed Web of Science ®Google Scholar
• Koudinov AR, Berezov TT, Kumar A, Koudinova NV. 1998. Alzheimer's amyloid beta interaction with normal human plasma high density lipoprotein: association with apolipoprotein and lipids. Clin Chim Acta 270:75–84.
   PubMed Web of Science ®Google Scholar
• Kuusisto J, Koivisto K, Mykkänen L, Helkala EL, Vanhanen M, Hänninen T, Kervinen K, Kesäniemi YA, Riekkinen PJ, Laakso M. 1997. Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study. BMJ. 315:1045–1049.
   PubMed Web of Science ®Google Scholar
• Lesser GT, Beeri MS, Schmeidler J, Purohit DP, Haroutunian V. 2011. Cholesterol and LDL relate to neuritic plaques and to APOE4 presence but not to neurofibrillary tangles. Curr Alzheimer Res. 8:303–312.
   PubMed Web of Science ®Google Scholar
• Li G, Shofer JB, Kukull WA, Peskind ER, Tsuang DW, Breitner JC, McCormick W, Bowen JD, Teri L, Schellenberg GD, et al. 2005. Serum cholesterol and risk of Alzheimer disease: a community-based cohort study . Neurology 65:1045–1050.
   PubMed Web of Science ®Google Scholar
• Lv YB, Yin ZX, Chei CL, Brasher MS, Zhang J, Kraus VB, Qian F, Shi XM, Matchar DB, Zeng Y. 2016. Serum cholesterol levels within the high normal range are associated with better cognitive performance among Chinese elderly. J Nutr Health Aging 20:280–287.
   PubMed Web of Science ®Google Scholar
• Ma C, Yin Z, Zhu P, Luo J, Shi X, Gao X. 2017. Blood cholesterol in late-life and cognitive decline: a longitudinal study of the Chinese elderly. Mol Neurodegener. 12:24.
   PubMed Web of Science ®Google Scholar
• Masters CL, Cappai R, Barnham KJ, Villemagne VL. 2006. Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics. J Neurochem. 97:1700–1725.
   PubMed Web of Science ®Google Scholar
• Murr J, Carmichael PH, Julien P, Laurin D. 2014. Plasma oxidized low-density lipoprotein levels and risk of Alzheimer’s disease. Neurobio Aging 35:1833–1838.
   PubMed Web of Science ®Google Scholar
• Olesen OF, Dagø L. 2000. High density lipoprotein inhibits assembly of amyloid beta-peptides into fibrils. Biochem Biophys Res Biochem Biophys Res Commun. 270:62–66.
   PubMed Web of Science ®Google Scholar
• Paul R, Choudhury A, Borah A. 2015. Cholesterol - A putative endogenous contributor towards Parkinson's disease. Neurochem Int. 90:125–133.
   PubMed Web of Science ®Google Scholar
• Petersen RC. 2004. Mild cognitive impairment as a diagnostic entity. J Intern Med. 256:183–194.
   PubMed Web of Science ®Google Scholar
• Qi Y, Liu J, Ma C, Wang W, Liu X, Wang M, Lv Q, Sun J, Liu J, Li Y, et al. 2013. Association between cholesterol synthesis/absorption markers and effects of cholesterol lowering by atorvastatin among patients with high risk of coronary heart disease. J Lipid Res 54:3189–3197.
   PubMed Web of Science ®Google Scholar
• Reitz C, Luchsinger J, Tang MX, Manly J, Mayeux R. 2005. Impact of plasma lipids and time on memory performance in healthy elderly without dementia. Neurology 64:1378–1383.
   PubMed Web of Science ®Google Scholar
• Shi J, Tian J, Pritchard A, Lendon C, Lambert JC, Iwatsubo T, Mann DM. 2006. A 3′-UTR polymorphism in the oxidized LDL receptor 1 gene increases Abeta40 load as cerebral amyloid angiopathy in Alzheimer's disease . Acta Neuropathol. 111:15–20.
   PubMed Web of Science ®Google Scholar
• Xia W, Zhang B, Yang Y, Wang P, Yang Y, Wang S. 2015. Poorly controlled cholesterol is associated with cognitive impairment in T2DM: a resting-state fMRI study. Lipids Health Dis. 14:47.
   PubMed Web of Science ®Google Scholar
• Xue-Shan Z, Juan P, Qi W, Zhong R, Li-Hong P, Zhi-Han T, Zhi-Sheng J, Gui-Xue W, Lu-Shan L. 2016. Imbalanced cholesterol metabolism in Alzheimer's disease. Clin Chim Acta 456:107–114.
   PubMed Web of Science ®Google Scholar
• Yaffe K, Barrett-Connor E, Lin F, Grady D. 2002. Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol. 59:378–384.
   PubMed Web of Science ®Google Scholar
• Yasuno F, Tanimukai S, Sasaki M, Ikejima C, Yamashita F, Kodama C, Hidaka S, Mizukami K, Asada T. 2012. Effect of plasma lipids, hypertension and APOE genotype on cognitive decline. Neurobio Aging 33:2633–2640.
   PubMed Web of Science ®Google Scholar
• Zhao N, Liu CC, Qiao W, Bu G. 2018. Apolipoprotein E, Receptors, and Modulation of Alzheimer's Disease. Biol Psychiatry 83:347–357.
   PubMed Web of Science ®Google Scholar